Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 934 entries
Sorted by: Best Match Show Resources per page
Comparison of electrophysiological effects of calcium channel blockers on cardiac repolarization.

The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology

Lee HA, Hyun SA, Park SG, Kim KS, Kim SJ.
PMID: 26807031
Korean J Physiol Pharmacol. 2016 Jan;20(1):119-27. doi: 10.4196/kjpp.2016.20.1.119. Epub 2015 Dec 31.

Dihydropyridine (DHP) calcium channel blockers (CCBs) have been widely used to treat of several cardiovascular diseases. An excessive shortening of action potential duration (APD) due to the reduction of Ca(2+) channel current (I Ca) might increase the risk of...

Cite
Lee HA, Hyun SA, Park SG, et al. Comparison of electrophysiological effects of calcium channel blockers on cardiac repolarization. Korean J Physiol Pharmacol. 2015;20(1):119-27doi: 10.4196/kjpp.2016.20.1.119.
Lee, H. A., Hyun, S. A., Park, S. G., Kim, K. S., & Kim, S. J. (2016). Comparison of electrophysiological effects of calcium channel blockers on cardiac repolarization. The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology, 20(1), 119-27. https://doi.org/10.4196/kjpp.2016.20.1.119
Lee, Hyang-Ae, et al. "Comparison of electrophysiological effects of calcium channel blockers on cardiac repolarization." The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology vol. 20,1 (2016): 119-27. doi: https://doi.org/10.4196/kjpp.2016.20.1.119
Lee HA, Hyun SA, Park SG, Kim KS, Kim SJ. Comparison of electrophysiological effects of calcium channel blockers on cardiac repolarization. Korean J Physiol Pharmacol. 2016 Jan;20(1):119-27. doi: 10.4196/kjpp.2016.20.1.119. Epub 2015 Dec 31. PMID: 26807031; PMCID: PMC4722185.
Copy Download .nbib Format: NLM
Tracheary-element differentiation in suspension-cultured cells ofZinnia requires uptake of extracellular Ca(2+) : Experiments with calcium-channel blockers and calmodulin inhibitors.

Planta

Roberts AW, Haigler CH.
PMID: 24202094
Planta. 1990 Mar;180(4):502-9. doi: 10.1007/BF02411447.

Tracheary-element (TE) differentiation in suspension cultures ofZinnia elegans L. mesophyll cells was inhibited by blocking calcium uptake in three ways: 1) reducing the [Ca(2+)] of the culture medium, 2) blocking calcium channels with the non-permeant cation La(3+), and 3)...

Cite
Roberts AW, Haigler CH. Tracheary-element differentiation in suspension-cultured cells ofZinnia requires uptake of extracellular Ca(2+) : Experiments with calcium-channel blockers and calmodulin inhibitors. Planta. 1990;180(4):502-9doi: 10.1007/BF02411447.
Roberts, A. W., & Haigler, C. H. (1990). Tracheary-element differentiation in suspension-cultured cells ofZinnia requires uptake of extracellular Ca(2+) : Experiments with calcium-channel blockers and calmodulin inhibitors. Planta, 180(4), 502-9. https://doi.org/10.1007/BF02411447
Roberts, A W, and Haigler, C H. "Tracheary-element differentiation in suspension-cultured cells ofZinnia requires uptake of extracellular Ca(2+) : Experiments with calcium-channel blockers and calmodulin inhibitors." Planta vol. 180,4 (1990): 502-9. doi: https://doi.org/10.1007/BF02411447
Roberts AW, Haigler CH. Tracheary-element differentiation in suspension-cultured cells ofZinnia requires uptake of extracellular Ca(2+) : Experiments with calcium-channel blockers and calmodulin inhibitors. Planta. 1990 Mar;180(4):502-9. doi: 10.1007/BF02411447. PMID: 24202094.
Copy Download .nbib Format: NLM
The induction of sporulation in the aquatic fungus blastocladiella emersonii is dependent on extracellular calcium.

FEMS microbiology letters

Coutinho EC, Correa LC.
PMID: 10518737
FEMS Microbiol Lett. 1999 Oct 15;179(2):353-9. doi: 10.1111/j.1574-6968.1999.tb08749.x.

Induction of sporulation in Blastocladiella emersonii is absolutely dependent on extracellular calcium. Vegetative cells grown in media with or without calcium do not sporulate in media devoid of calcium or in CaCl(2) with EGTA. Calcium channel blockers, CoCl(2) and...

Cite
Coutinho EC, Correa LC. The induction of sporulation in the aquatic fungus blastocladiella emersonii is dependent on extracellular calcium. FEMS Microbiol Lett. 1999;179(2):353-9doi: 10.1111/j.1574-6968.1999.tb08749.x.
Coutinho, E. C., & Correa, L. C. (1999). The induction of sporulation in the aquatic fungus blastocladiella emersonii is dependent on extracellular calcium. FEMS microbiology letters, 179(2), 353-9. https://doi.org/10.1111/j.1574-6968.1999.tb08749.x
Coutinho, and Correa. "The induction of sporulation in the aquatic fungus blastocladiella emersonii is dependent on extracellular calcium." FEMS microbiology letters vol. 179,2 (1999): 353-9. doi: https://doi.org/10.1111/j.1574-6968.1999.tb08749.x
Coutinho EC, Correa LC. The induction of sporulation in the aquatic fungus blastocladiella emersonii is dependent on extracellular calcium. FEMS Microbiol Lett. 1999 Oct 15;179(2):353-9. doi: 10.1111/j.1574-6968.1999.tb08749.x. PMID: 10518737.
Copy Download .nbib Format: NLM
Calcium channel blockers and depression: a cohort study.

Hospital medicine (London, England : 1998)

[No authors listed]
PMID: 10621801
Hosp Med. 1999 Sep;60(9):685.

No abstract available.

Cite
Calcium channel blockers and depression: a cohort study. Hosp Med. 1999;60(9):685
(1999). Calcium channel blockers and depression: a cohort study. Hospital medicine (London, England : 1998), 60(9), 685.
"Calcium channel blockers and depression: a cohort study." Hospital medicine (London, England : 1998) vol. 60,9 (1999): 685.
Calcium channel blockers and depression: a cohort study. Hosp Med. 1999 Sep;60(9):685. PMID: 10621801.
Copy Download .nbib Format: NLM
Left Ventricular Hypertrophy.

Current treatment options in cardiovascular medicine

Liebson PR.
PMID: 11096487
Curr Treat Options Cardiovasc Med. 1999 Oct;1(3):219-230. doi: 10.1007/s11936-999-0038-0.

The presence of left ventricular hypertrophy (LVH) as a treatable entity is of particular importance in patients with primary hypertension. Because LVH is associated with a strong risk of adverse clinical events (eg, heart failure, ischemic events, and cardiovascular...

Cite
Liebson PR. Left Ventricular Hypertrophy. Curr Treat Options Cardiovasc Med. 1999;1(3):219-230doi: 10.1007/s11936-999-0038-0.
Liebson, P. R. (1999). Left Ventricular Hypertrophy. Current treatment options in cardiovascular medicine, 1(3), 219-230. https://doi.org/10.1007/s11936-999-0038-0
Liebson. "Left Ventricular Hypertrophy." Current treatment options in cardiovascular medicine vol. 1,3 (1999): 219-230. doi: https://doi.org/10.1007/s11936-999-0038-0
Liebson PR. Left Ventricular Hypertrophy. Curr Treat Options Cardiovasc Med. 1999 Oct;1(3):219-230. doi: 10.1007/s11936-999-0038-0. PMID: 11096487.
Copy Download .nbib Format: NLM
The Calcium Channel Blockers.

American journal of therapeutics

Somberg JC.
PMID: 11850653
Am J Ther. 1995 Apr;2(4):231-232.

No abstract available.

Cite
Somberg JC. The Calcium Channel Blockers. Am J Ther. 1995;2(4):231-232
Somberg, J. C. (1995). The Calcium Channel Blockers. American journal of therapeutics, 2(4), 231-232.
Somberg, John C.. "The Calcium Channel Blockers." American journal of therapeutics vol. 2,4 (1995): 231-232.
Somberg JC. The Calcium Channel Blockers. Am J Ther. 1995 Apr;2(4):231-232. PMID: 11850653.
Copy Download .nbib Format: NLM
Large-Scale Postmarketing Surveillance of Hypertensive Patients Treated with Verapamil.

American journal of therapeutics

Cobb MM, Johnson D, Gallo J, Crawley JA, Cargo PH, Lefkowitz MP.
PMID: 11850691
Am J Ther. 1995 Jul;2(7):455-461. doi: 10.1097/00045391-199506000-00003.

BACKGROUND: In general clinical practice, physicians prescribe calcium channel blockers to a wide range of patients with differing demographic characteristics and hypertension history. This study was undertaken to investigate the effectiveness and safety of sustained-release verapamil (Verelan((R)), verapamil HCl)...

Cite
Cobb MM, Johnson D, Gallo J, et al. Large-Scale Postmarketing Surveillance of Hypertensive Patients Treated with Verapamil. Am J Ther. 1995;2(7):455-461doi: 10.1097/00045391-199506000-00003.
Cobb, M. M., Johnson, D., Gallo, J., Crawley, J. A., Cargo, P. H., & Lefkowitz, M. P. (1995). Large-Scale Postmarketing Surveillance of Hypertensive Patients Treated with Verapamil. American journal of therapeutics, 2(7), 455-461. https://doi.org/10.1097/00045391-199506000-00003
Cobb, Margaret M., et al. "Large-Scale Postmarketing Surveillance of Hypertensive Patients Treated with Verapamil." American journal of therapeutics vol. 2,7 (1995): 455-461. doi: https://doi.org/10.1097/00045391-199506000-00003
Cobb MM, Johnson D, Gallo J, Crawley JA, Cargo PH, Lefkowitz MP. Large-Scale Postmarketing Surveillance of Hypertensive Patients Treated with Verapamil. Am J Ther. 1995 Jul;2(7):455-461. doi: 10.1097/00045391-199506000-00003. PMID: 11850691.
Copy Download .nbib Format: NLM
Hypothesis to explain poor outcomes in the ALLHAT and V-HeFT trials: decreased expression of heat shock proteins.

Current controlled trials in cardiovascular medicine

Hooper PL.
PMID: 11806806
Curr Control Trials Cardiovasc Med. 2001;2(6):251-253. doi: 10.1186/cvm-2-6-251.

An explanation for the higher incidence of cardiovascular disease and heart failure in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) with doxazosin and the Vasodilator Heart Failure Trial (V-HeFT) with prazosin might be decreased expression...

Cite
Hooper PL. Hypothesis to explain poor outcomes in the ALLHAT and V-HeFT trials: decreased expression of heat shock proteins. Curr Control Trials Cardiovasc Med. 2001;2(6):251-253doi: 10.1186/cvm-2-6-251.
Hooper, P. L. (2001). Hypothesis to explain poor outcomes in the ALLHAT and V-HeFT trials: decreased expression of heat shock proteins. Current controlled trials in cardiovascular medicine, 2(6), 251-253. https://doi.org/10.1186/cvm-2-6-251
Hooper, Philip L. "Hypothesis to explain poor outcomes in the ALLHAT and V-HeFT trials: decreased expression of heat shock proteins." Current controlled trials in cardiovascular medicine vol. 2,6 (2001): 251-253. doi: https://doi.org/10.1186/cvm-2-6-251
Hooper PL. Hypothesis to explain poor outcomes in the ALLHAT and V-HeFT trials: decreased expression of heat shock proteins. Curr Control Trials Cardiovasc Med. 2001;2(6):251-253. doi: 10.1186/cvm-2-6-251. PMID: 11806806; PMCID: PMC64823.
Copy Download .nbib Format: NLM
A 75-kDa polypeptide, located primarily at the plasma membrane of carrot cell-suspension cultures, is photoaffinity labeled by the calcium channel blocker LU 49888.

Proceedings of the National Academy of Sciences of the United States of America

Thuleau P, Graziana A, Canut H, Ranjeva R.
PMID: 11607139
Proc Natl Acad Sci U S A. 1990 Dec 15;87(24):10000-4. doi: 10.1073/pnas.87.24.10000.

Calcium channel blockers of the phenylalkylamine family bind specifically to membranes and inhibit calcium uptake in carrot protoplast. LU 49888, an azido derivative of phenylalkylamine, behaves as its unmodified homolog in terms of affinity and specificity and therefore allows...

Cite
Thuleau P, Graziana A, Canut H, et al. A 75-kDa polypeptide, located primarily at the plasma membrane of carrot cell-suspension cultures, is photoaffinity labeled by the calcium channel blocker LU 49888. Proc Natl Acad Sci U S A. 1990;87(24):10000-4doi: 10.1073/pnas.87.24.10000.
Thuleau, P., Graziana, A., Canut, H., & Ranjeva, R. (1990). A 75-kDa polypeptide, located primarily at the plasma membrane of carrot cell-suspension cultures, is photoaffinity labeled by the calcium channel blocker LU 49888. Proceedings of the National Academy of Sciences of the United States of America, 87(24), 10000-4. https://doi.org/10.1073/pnas.87.24.10000
Thuleau, P, et al. "A 75-kDa polypeptide, located primarily at the plasma membrane of carrot cell-suspension cultures, is photoaffinity labeled by the calcium channel blocker LU 49888." Proceedings of the National Academy of Sciences of the United States of America vol. 87,24 (1990): 10000-4. doi: https://doi.org/10.1073/pnas.87.24.10000
Thuleau P, Graziana A, Canut H, Ranjeva R. A 75-kDa polypeptide, located primarily at the plasma membrane of carrot cell-suspension cultures, is photoaffinity labeled by the calcium channel blocker LU 49888. Proc Natl Acad Sci U S A. 1990 Dec 15;87(24):10000-4. doi: 10.1073/pnas.87.24.10000. PMID: 11607139; PMCID: PMC55302.
Copy Download .nbib Format: NLM
[Secondary prevention in acute myocardial infarction].

Acta medica portuguesa

Ferreira R, Ferreira D, Correia MJ, De Sá ME, De Sousa JV, Sousa JV, Tavares MG.
PMID: 11475986
Acta Med Port. 2001 Mar-Apr;14(2):149-69.

Myocardial infarction is still one of the main causes of mortality and morbidity in Western countries. The advances made in the last 30 years have made it possible to reduce mortality significantly (which is currently below two digits) as...

Cite
Ferreira R, Ferreira D, Correia MJ, et al. Prevenção secundária no enfarte agudo do miocárdio. [Secondary prevention in acute myocardial infarction]. Acta Med Port. 2001;14(2):149-69
Ferreira, R., Ferreira, D., Correia, M. J., De Sá, M. E., De Sousa, J. V., Sousa, J. V., & Tavares, M. G. (2001). Prevenção secundária no enfarte agudo do miocárdio. [Secondary prevention in acute myocardial infarction]. Acta medica portuguesa, 14(2), 149-69.
Ferreira, R, et al. "Prevenção secundária no enfarte agudo do miocárdio." [Secondary prevention in acute myocardial infarction]. Acta medica portuguesa vol. 14,2 (2001): 149-69.
Ferreira R, Ferreira D, Correia MJ, De Sá ME, De Sousa JV, Sousa JV, Tavares MG. Prevenção secundária no enfarte agudo do miocárdio. [Secondary prevention in acute myocardial infarction]. Acta Med Port. 2001 Mar-Apr;14(2):149-69. Portuguese. PMID: 11475986.
Copy Download .nbib Format: NLM
Reflex Sympathetic Dystrophy in the Upper Extremity.

The Journal of the American Academy of Orthopaedic Surgeons

Gellman H, Nichols D.
PMID: 10795066
J Am Acad Orthop Surg. 1997 Nov;5(6):313-322. doi: 10.5435/00124635-199711000-00003.

The diagnosis and treatment of pain are among the most challenging problems facing orthopaedic surgeons, and reflex sympathetic dystrophy is probably the most frustrating and difficult pain syndrome to manage. Pain, swelling, and autonomic dysfunction are cardinal signs of...

Cite
Gellman H, Nichols D. Reflex Sympathetic Dystrophy in the Upper Extremity. J Am Acad Orthop Surg. 1997;5(6):313-322doi: 10.5435/00124635-199711000-00003.
Gellman, H., & Nichols, D. (1997). Reflex Sympathetic Dystrophy in the Upper Extremity. The Journal of the American Academy of Orthopaedic Surgeons, 5(6), 313-322. https://doi.org/10.5435/00124635-199711000-00003
Gellman, and Nichols. "Reflex Sympathetic Dystrophy in the Upper Extremity." The Journal of the American Academy of Orthopaedic Surgeons vol. 5,6 (1997): 313-322. doi: https://doi.org/10.5435/00124635-199711000-00003
Gellman H, Nichols D. Reflex Sympathetic Dystrophy in the Upper Extremity. J Am Acad Orthop Surg. 1997 Nov;5(6):313-322. doi: 10.5435/00124635-199711000-00003. PMID: 10795066.
Copy Download .nbib Format: NLM
Treatment of Older Patients With CHF Associated With Normal LVEF.

The American journal of geriatric cardiology

Aronow WS.
PMID: 11416478
Am J Geriatr Cardiol. 1998 Nov;7(6):27-31.

CHF with a normal LVEF should be treated with a low salt diet, cautious use of loop diuretics, and à -blockers. If CHF persists despite the use of diuretics and à -blockers, ACE inhibitors should be administered. If the...

Cite
Aronow WS. Treatment of Older Patients With CHF Associated With Normal LVEF. Am J Geriatr Cardiol. 1998;7(6):27-31
Aronow, W. S. (1998). Treatment of Older Patients With CHF Associated With Normal LVEF. The American journal of geriatric cardiology, 7(6), 27-31.
Aronow, Wilbert S.. "Treatment of Older Patients With CHF Associated With Normal LVEF." The American journal of geriatric cardiology vol. 7,6 (1998): 27-31.
Aronow WS. Treatment of Older Patients With CHF Associated With Normal LVEF. Am J Geriatr Cardiol. 1998 Nov;7(6):27-31. PMID: 11416478.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 934 entries